Journal Information
Case and Research Letter
Full text access
Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience
Los inhibidores selectivos de la IL23 son en su mayoría efectivos y seguros en pacientes con psoriasis y fallo previo a tratamientos biológicos anti IL-17. Una experiencia de práctica clínica real a 52 semanas
J. Arroyo-Andrés
, D. Falkenhain-López, M. Agud-Dios, R. Rivera-Díaz
Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

Article

This article is available in English

Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience

J. Arroyo-Andrés, D. Falkenhain-López, M. Agud-Dios, R. Rivera-Díaz
10.1016/j.ad.2022.05.035
Actas Dermosifiliogr. 2023;114:363-5
Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?